Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis

• Egile Nagusiak: Zhen Liu (Egilea), Zimu Zhang (Egilea), Juan Sun (Egilea), Jie Li (Egilea), Ziyang Zeng (Egilea), Mingwei Ma (Egilea), Xin Ye (Egilea), Fan Feng (Egilea), Weiming Kang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Significant survival benefit of adjuvant imatinib therapy has been observed in gastrointestinal stromal tumor (GIST). However, the impact of neoadjuvant imatinib on prognosis of GIST remains unclear. This meta-analysis aimed to compare the prognostic impact between upfront surgery and ne...